Further research is needed to elucidate how these combined exercises influence key molecular pathways, such as the IGF-1/PI3K/AKT/FOXO3 axis, to enhance therapeutic strategies for sarcopenia. This evidence concerns the gene FOXO3 and sarcopenia.